The pharmacological pathway in the NICE guidelines on T2DM (NG28) is metformin as first line, or a choice of sulfonylurea (SU), pioglitazone, DPP-4 inhibitor, or SGLT-2 inhibitor if metformin not...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills